Cargando…

Insurance status impacts survival of hepatocellular carcinoma patients after liver resection

BACKGROUND: This study intends to examine the effect of public insurance status on survival outcomes of HCC patients after liver resection in China. METHODS: We divided 2911 HCC patients after liver resection included in our study into the Urban Employed‐based Medical Insurance group (UEBMI group, n...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Zhancheng, Qi, Weili, Wu, Youwei, Li, Lingling, Li, Chuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501234/
https://www.ncbi.nlm.nih.gov/pubmed/37455560
http://dx.doi.org/10.1002/cam4.6339
_version_ 1785106076540076032
author Qiu, Zhancheng
Qi, Weili
Wu, Youwei
Li, Lingling
Li, Chuan
author_facet Qiu, Zhancheng
Qi, Weili
Wu, Youwei
Li, Lingling
Li, Chuan
author_sort Qiu, Zhancheng
collection PubMed
description BACKGROUND: This study intends to examine the effect of public insurance status on survival outcomes of HCC patients after liver resection in China. METHODS: We divided 2911 HCC patients after liver resection included in our study into the Urban Employed‐based Medical Insurance group (UEBMI group, n = 1462) and the non‐Urban Employed‐based Medical Insurance group (non‐UEBMI group, n = 1449). A propensity score matching (PSM) analysis was used to control confounding factors. Overall survival (OS) was estimated by Kaplan–Meier curves and Cox proportional hazard models based on variables screened by Lasso regression. Competing risk analysis was used to analyze cancer‐specific survival (CSS). RESULTS: UEBMI group had more male patients (p = 0.031), patients in the UEBMI group were older (p < 0.001) and had lower Charlson Comorbidity Index scores (CCI score, p < 0.001). Meanwhile, patients in the UEBMI group had better liver function (albumin‐bilirubin grade I [ALBI I], p < 0.001) and lower tumor burden (α‐fetoprotein [AFP], p = 0.009; Barcelona Clinic Liver Cancer stage [BCLC], p = 0.026; Milan criteria, p < 0.001; tumor size, p < 0.001; microvascular invasion [MVI], p = 0.030; portal vein tumor thrombosis [PVTT], p = 0.002). More patients in the UEBMI group received laparoscopic surgery (p = 0.024) and adjuvant transarterial chemoembolization (TACE, p < 0.001). After PSM, patients in the two matched groups had similar characteristics. Patients with recurrent HCC in the UEBMI were more likely to receive curative therapy (p < 0.001) and less likely to receive supportive care (p < 0.001). HCC patients after liver resection in the non‐UEBMI group had a worse OS before (p < 0.0001) and after PSM (p = 0.002). [Correction added on August 16, 2023 after first online publication. The p value has been updated in the preceding sentence.] In our Lasso‐Cox risk regression model, public health insurance status was an independent factor linked with OS (non‐UEBMI vs. UEBMI, hazard ratio [HR]: 1.27; 95% confidence interval [CI]: 1.12–1.46; p < 0.001). In the competing risk analysis, patients in the UEBMI group had a lower cumulative incidence of CSS before (p < 0.001) and after PSM (p = 0.001), and public insurance status of HCC patients after liver resection remained independently associated with CSS (non‐UEBMI vs. UEBMI; HR:1.36; 95% CI: 1.18–1.58; p < 0.001). CONCLUSIONS: Underinsured HCC patients after liver resection had worse survival outcomes. Less access to care for underinsured patients may explain the difference in survival, but the corresponding conclusions need to be further explored.
format Online
Article
Text
id pubmed-10501234
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-105012342023-09-15 Insurance status impacts survival of hepatocellular carcinoma patients after liver resection Qiu, Zhancheng Qi, Weili Wu, Youwei Li, Lingling Li, Chuan Cancer Med RESEARCH ARTICLES BACKGROUND: This study intends to examine the effect of public insurance status on survival outcomes of HCC patients after liver resection in China. METHODS: We divided 2911 HCC patients after liver resection included in our study into the Urban Employed‐based Medical Insurance group (UEBMI group, n = 1462) and the non‐Urban Employed‐based Medical Insurance group (non‐UEBMI group, n = 1449). A propensity score matching (PSM) analysis was used to control confounding factors. Overall survival (OS) was estimated by Kaplan–Meier curves and Cox proportional hazard models based on variables screened by Lasso regression. Competing risk analysis was used to analyze cancer‐specific survival (CSS). RESULTS: UEBMI group had more male patients (p = 0.031), patients in the UEBMI group were older (p < 0.001) and had lower Charlson Comorbidity Index scores (CCI score, p < 0.001). Meanwhile, patients in the UEBMI group had better liver function (albumin‐bilirubin grade I [ALBI I], p < 0.001) and lower tumor burden (α‐fetoprotein [AFP], p = 0.009; Barcelona Clinic Liver Cancer stage [BCLC], p = 0.026; Milan criteria, p < 0.001; tumor size, p < 0.001; microvascular invasion [MVI], p = 0.030; portal vein tumor thrombosis [PVTT], p = 0.002). More patients in the UEBMI group received laparoscopic surgery (p = 0.024) and adjuvant transarterial chemoembolization (TACE, p < 0.001). After PSM, patients in the two matched groups had similar characteristics. Patients with recurrent HCC in the UEBMI were more likely to receive curative therapy (p < 0.001) and less likely to receive supportive care (p < 0.001). HCC patients after liver resection in the non‐UEBMI group had a worse OS before (p < 0.0001) and after PSM (p = 0.002). [Correction added on August 16, 2023 after first online publication. The p value has been updated in the preceding sentence.] In our Lasso‐Cox risk regression model, public health insurance status was an independent factor linked with OS (non‐UEBMI vs. UEBMI, hazard ratio [HR]: 1.27; 95% confidence interval [CI]: 1.12–1.46; p < 0.001). In the competing risk analysis, patients in the UEBMI group had a lower cumulative incidence of CSS before (p < 0.001) and after PSM (p = 0.001), and public insurance status of HCC patients after liver resection remained independently associated with CSS (non‐UEBMI vs. UEBMI; HR:1.36; 95% CI: 1.18–1.58; p < 0.001). CONCLUSIONS: Underinsured HCC patients after liver resection had worse survival outcomes. Less access to care for underinsured patients may explain the difference in survival, but the corresponding conclusions need to be further explored. John Wiley and Sons Inc. 2023-07-16 /pmc/articles/PMC10501234/ /pubmed/37455560 http://dx.doi.org/10.1002/cam4.6339 Text en © 2023 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle RESEARCH ARTICLES
Qiu, Zhancheng
Qi, Weili
Wu, Youwei
Li, Lingling
Li, Chuan
Insurance status impacts survival of hepatocellular carcinoma patients after liver resection
title Insurance status impacts survival of hepatocellular carcinoma patients after liver resection
title_full Insurance status impacts survival of hepatocellular carcinoma patients after liver resection
title_fullStr Insurance status impacts survival of hepatocellular carcinoma patients after liver resection
title_full_unstemmed Insurance status impacts survival of hepatocellular carcinoma patients after liver resection
title_short Insurance status impacts survival of hepatocellular carcinoma patients after liver resection
title_sort insurance status impacts survival of hepatocellular carcinoma patients after liver resection
topic RESEARCH ARTICLES
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501234/
https://www.ncbi.nlm.nih.gov/pubmed/37455560
http://dx.doi.org/10.1002/cam4.6339
work_keys_str_mv AT qiuzhancheng insurancestatusimpactssurvivalofhepatocellularcarcinomapatientsafterliverresection
AT qiweili insurancestatusimpactssurvivalofhepatocellularcarcinomapatientsafterliverresection
AT wuyouwei insurancestatusimpactssurvivalofhepatocellularcarcinomapatientsafterliverresection
AT lilingling insurancestatusimpactssurvivalofhepatocellularcarcinomapatientsafterliverresection
AT lichuan insurancestatusimpactssurvivalofhepatocellularcarcinomapatientsafterliverresection